Peers of Sellas Life Sciences Group Inc (SLS)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
11.88x
As of Mar 30, 2023
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Mar 30, 2023 | 11.88x |
| Mar 29, 2023 | 9.15x |
| Mar 28, 2023 | 7.68x |
| Mar 27, 2023 | 8.10x |
| Mar 24, 2023 | 8.73x |
| Mar 23, 2023 | 8.52x |
| Mar 22, 2023 | 8.94x |
| Mar 21, 2023 | 10.20x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison